Tuesday, October 19 2021

Mysterious Big Pharmaceutical Company Eyes US Biotech Acceleron

Edward D. Friedland

The identity of the mysterious Cambridge-Massachusetts-based biotechnology-based big pharmaceutical company Acceleron has yet to be confirmed, but US media points […]

Read More 0

ADQ acquires Swiss pharmaceutical company Acino

Edward D. Friedland

ADQ, one of the largest holding companies in the region, has reached a definitive agreement to purchase Swiss pharmaceutical company […]

Read More 0

Burton pharmaceutical company profits drop

Edward D. Friedland

Profits fell as revenues rose at Clinigen, the pharmaceutical and service group, according to annual results for the fiscal year […]

Read More 0

Could protein engineers have built the next billion pound pharmaceutical company?

Edward D. Friedland

Peptone uses science to create the world’s first protein engineering operating system, combining AI and computational molecular physics. Above, a […]

Read More 0

Pharmaceutical company in H&H finishing expenses

Edward D. Friedland

Pharmaceutical industry specialist CST Pharma increased its productivity with the acquisition of a Herzog + Heyman (H + H) pocket […]

Read More 0

5 shares of pharmaceutical companies working on COVID-19 vaccines

Edward D. Friedland

5 shares of pharmaceutical companies working on a vaccine against the coronavirus Pharmaceutical company Current market price Vaccine Dr Reddy’s […]

Read More 0

Ex-Mossad chief joins pharmaceutical company marketing Israeli vaccine against COVID

Edward D. Friedland

Former Mossad chief Tamir Pardo has joined NRx Pharmaceuticals, the company that is completing clinical trials for Israel’s COVID-19 vaccine, […]

Read More 0

Vaccine Scam Fake Brain May Also Have Targeted Pharmaceutical Company Malad | Bombay News

Edward D. Friedland

MUMBAI: Could the fake vaccine scam that erupted in the city earlier this year have impacted more people? The Kandivali […]

Read More 0

How this pharmaceutical company is embracing hybrid work

Edward D. Friedland

MSD’s Mark Nolan explains how the pharmaceutical company is going hybrid and what companies need to think about as the […]

Read More 0

Open Orphan wins € 9.5 million asthma contract with major pharmaceutical company

Edward D. Friedland

Dublin-listed pharmacy services company Open Orphan said its subsidiary hVivo had signed a £ 8.1million (€ 9.5million) asthma contract with […]

Read More 0
1 2 3 4 7